Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
10 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
General Motors reported third-quarter revenue of $50.02 billion, up 2.9% year over year and above the $48.53 billion market consensus. EBIT was $4.11 billion versus BNP Paribas’s $4.26 billion forecast, while EPS was $3.70 versus its $3.74 forecast.
U.S. stock futures swung between gains and losses Tuesday, with the Dow Jones up 0.19%; the report says the S&P 500 and Nasdaq 100 fell. It also cites an Iranian official’s threat to target undersea communication cables in the Strait of Hormuz.
U.S. stock futures rose Wednesday ahead of the September CPI release. The Dow Jones, S&P 500 and Nasdaq 100 were higher after Tuesday’s lower close.
Jefferies kept Porsche at hold with a 49 euro target after investor-event remarks on margins and cash returns. UBS raised Volvo to buy and Bernstein upgraded Continental to outperform, while shares in the sector were mixed.
The Nasdaq composite fell 1.3% in a mixed session as AI-related shares slid after reports of lower-than-expected OpenAI revenue. Oil prices rose after President Donald Trump's remarks on the Middle East war, while Federal Reserve Gov. Christopher Waller said additional rate hikes may be needed.
Aritzia reported second-quarter and year-to-date results, including net revenue growth, higher profit and an increase in inventory. The company also said it repurchased 912,800 subordinate voting shares under its NCIB.
Bitcoin moved down to around $81,500 in afternoon trade as major U.S. stock indexes stayed lower and Treasury yields eased. The move came alongside broader risk-off action tied to oil, Fed comments and tech-sector weakness.
Bitcoin fell to around $81,500 in afternoon trade as broader markets reacted to higher oil prices and hawkish Federal Reserve comments.
Bitcoin moved down to around $80,800 in Thursday afternoon trading as Wall Street weakened. The move was reported alongside broader declines in U.S. stocks and a drop in Treasury yields.
For best results when printing this announcement, please click on link below: RNS Number: 0622W BioPharma Credit PLC 24 September 2026 24 September 2026 BIOPHARMA CREDIT PLC ("BPCR" or "the Company") HALF YEAR REPORT FOR THE YEAR ENDED 30 JUNE 2026 BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt inv